₹1,780.4
▲ +21.46 +1.22%
As of 27 Jul 2026 · delayed
NSE Listed
Laurus Labs Limited (LAURUSLABS)
Volume: 79,89,358Avg Vol 1W: 29,57,969Avg Vol 1M: 22,49,976.7552W Range:₹810.05₹1,797.9
Key Ratios
Checked 1d agoMarket Cap₹92,269 Cr
Current Price₹1,780.4
Previous Close₹1,758.94
High / Low (52w)₹1,797.9 / ₹810.05
Volume79,89,358
Avg Vol (1W)29,57,969
Avg Vol (1M)22,49,976.75
Stock P/E330.35
Book Value₹98.18
Dividend Yield0.1%
ROE16.8%
ROA8.5%
Revenue (TTM)₹6,868 Cr
Revenue Growth22.7%
Profit Margin13.1%
Total Debt₹611 Cr
Shares Outstanding54 Cr
Face Value₹2
EPS (TTM)₹5.17
P/B17.4
Debt / Equity0.48
50 DMA₹1,474.5
200 DMA₹1,158.2
Day change+1.22%
Price Chart
₹1,780.4▲ 95.68% · 1Y
2025-07-292026-07-27
20-day avg volume: 22.5L shares
Pros
- Healthy return on equity of 16.8%.
- Company is almost debt-free.
Cons
- Revenue fell 19% YoY.
- Stock trades at a high P/E of 330.
Quarterly Results
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1,224 Cr | ₹1,415 Cr | ₹1,720 Cr | ₹1,570 Cr | ₹1,653 Cr | ₹1,778 Cr | ₹1,812 Cr | ₹2,026 Cr |
| EBITDA | ₹75 Cr | ₹188 Cr | ₹369 Cr | ₹276 Cr | ₹310 Cr | ₹365 Cr | ₹402 Cr | ₹524 Cr |
| Net Profit | ₹20 Cr | ₹92 Cr | ₹234 Cr | ₹163 Cr | ₹195 Cr | ₹252 Cr | ₹279 Cr | ₹368 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹5,629 Cr | ₹1,650 Cr | ₹1,433 Cr | ₹1,567 Cr | ₹1,509 Cr | ₹1,580 Cr | ₹6,868 Cr | ₹1,757 Cr |
| EBITDA | ₹700 Cr | ₹379 Cr | ₹255 Cr | ₹323 Cr | ₹266 Cr | ₹293 Cr | ₹1,353 Cr | ₹423 Cr |
| Net Profit | ₹358 Cr | ₹252 Cr | ₹158 Cr | ₹216 Cr | ₹175 Cr | ₹192 Cr | ₹889 Cr | ₹290 Cr |
| EPS | 6.64 | — | — | — | — | — | 16.45 | — |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹3,331 Cr | ₹3,750 Cr | ₹5,751 Cr | ₹6,968 Cr | ₹7,660 Cr | ₹8,387 Cr | ₹9,336 Cr | ₹10,511 Cr |
| Total Liabilities | ₹1,773 Cr | ₹1,981 Cr | ₹3,150 Cr | ₹3,609 Cr | ₹3,612 Cr | ₹4,271 Cr | ₹4,733 Cr | ₹5,080 Cr |
| Equity | ₹1,558 Cr | ₹1,770 Cr | ₹2,601 Cr | ₹3,359 Cr | ₹4,049 Cr | ₹4,116 Cr | ₹4,603 Cr | ₹5,431 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹323 Cr | ₹387 Cr | ₹962 Cr | ₹1,093 Cr | ₹1,279 Cr | ₹770 Cr | ₹739 Cr | ₹1,917 Cr |
| Investing | ₹-253 Cr | ₹-221 Cr | ₹-941 Cr | ₹-914 Cr | ₹-996 Cr | ₹-822 Cr | ₹-682 Cr | ₹-1,089 Cr |
| Financing | ₹-45 Cr | ₹-128 Cr | ₹255 Cr | ₹30 Cr | ₹-27 Cr | ₹250 Cr | ₹39 Cr | ₹-525 Cr |
| Free Cash Flow | ₹323 Cr | ₹387 Cr | ₹962 Cr | ₹1,093 Cr | ₹1,279 Cr | ₹770 Cr | ₹739 Cr | ₹1,917 Cr |
Shareholding
Promoter 27.47% Institutions 41.74% Public 30.78%
Efficiency & Working Capital
ROCE15%
Interest Coverage7.9
Dividend Payout—
Debtor Days115 d
Inventory Days125 d
Payable Days67 d
Cash Conversion Cycle174 d
Working Capital Days241 d
Shareholding Details
As of 2026-06-30
Promoter27.5%
FII28%
DII13.7%
Institutions41.7%
Public30.8%
Promoter Pledge2.7%
No. of Shareholders2,91,653
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 27.2% | 27.2% | 27.2% | 27.2% | 27.2% | 27.6% | 27.6% | 27.6% | 27.6% | 27.5% | 27.5% | 27.5% |
| FIIs | 24% | 25.4% | 26% | 25.7% | 26.1% | 25.6% | 25.5% | 25.7% | 26.2% | 26.5% | 25.8% | 28% |
| DIIs | 10.7% | 10.8% | 11.8% | 13.6% | 13% | 12.7% | 11.8% | 11.9% | 11.7% | 12.4% | 14% | 13.7% |
| Public | 38.1% | 36.7% | 35.1% | 33.6% | 33.7% | 34.1% | 35.1% | 34.8% | 34.5% | 33.6% | 32.7% | 30.8% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 2.7% | 2.7% | 2.7% | 2.7% | 2.7% | 2.7% | 2.7% |
| No. of Shareholders | 4,02,640 | 3,82,880 | 3,56,830 | 3,24,059 | 3,09,063 | 2,92,214 | 2,92,905 | 2,80,223 | 2,83,678 | 2,80,756 | 2,92,281 | 2,91,653 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| M/s. Nsn Holdings (represented By Its Managing Partner, Dr. Satyanarayana Chava) | Shareholding of Promoter and Promoter Group | 23% | 12.41 Cr |
| Mirae Asset Large & Midcap Fund | Public Shareholding | 4.3% | 2.34 Cr |
| New World Fund Inc | Public Shareholding | 4.3% | 2.31 Cr |
| Anukar Projects Private Limited | Public Shareholding | 3.2% | 1.75 Cr |
| Smallcap World Fund, Inc | Public Shareholding | 2.8% | 1.49 Cr |
| Chunduru Venkata Lakshmana Rao | Shareholding of Promoter and Promoter Group | 2.7% | 1.43 Cr |
| Barclays Wealth Trustees India Private Limited | Public Shareholding | 1.6% | 83,56,485 |
| Akash Bhanshali | Public Shareholding | 1.3% | 71,51,700 |
| M/s. Leven Holdings (represented By Its Managing Partner, Mr. Venkata Ravi Kumar Vantaram) | Shareholding of Promoter and Promoter Group | 1.2% | 62,05,000 |
| Kotak Funds - India Midcap Fund | Public Shareholding | 1% | 54,32,891 |
| Satyanarayana Chava | Shareholding of Promoter and Promoter Group | 0.3% | 15,70,000 |
| Venkata Ravi Kumar Vantaram | Shareholding of Promoter and Promoter Group | 0.2% | 10,00,000 |
| Krishnaveni Vasireddi | Shareholding of Promoter and Promoter Group | 0% | 2,01,401 |
| Hymavathi Vantaram | Shareholding of Promoter and Promoter Group | 0% | 2,25,000 |
| Rama Suryadevara | Shareholding of Promoter and Promoter Group | 0% | 1,40,000 |
| Narasimha Rao Suryadevara | Shareholding of Promoter and Promoter Group | 0% | 1,47,500 |
| Nagamani Thokala | Shareholding of Promoter and Promoter Group | 0% | 1,00,000 |
| Kamala Kommana | Shareholding of Promoter and Promoter Group | 0% | 1,00,000 |
| Sekhar Babu Chunduru | Shareholding of Promoter and Promoter Group | 0% | 1,00,000 |
| Chava Narasimha Rao | Shareholding of Promoter and Promoter Group | 0% | 1,19,675 |
| Chandrakanth Chereddi | Shareholding of Promoter and Promoter Group | 0% | 42,000 |
| Chava Naga Rani | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Soumya Chava | Shareholding of Promoter and Promoter Group | 0% | 22,940 |
| Krishna Chaitanya Chava | Shareholding of Promoter and Promoter Group | 0% | 20,699 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Chunduru Venkata Lakshmana Rao | 40,00,000 | 28% | 2026-06-30 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Ravindranath Kancherla | Chairman & Independent Directo | 2026 |
| CHAVA SATYANARAYANA | Executive Director & CEO | 2026 |
| VENKATA RAVI KUMAR VANTARAM | Executive Director & CFO | 2026 |
| Venkata Lakshmana Rao Chunduru | Executive Director | 2026 |
| KRISHNA CHAITANYA CHAVA | Executive Director | 2026 |
| Soumya Chava | Executive Director | 2026 |
| Aruna Bhinge | Independent Non Exe. Director | 2026 |
| Rajesh Koshy Chandy | Independent Non Exe. Director | 2026 |
| Karnam Sekar | Independent Non Exe. Director | 2026 |
| Ramesh Subrahmanian | Independent Non Exe. Director | 2026 |
| Sutapa Banerjee | Independent Director | 2026 |
| Shekhar Chintamani Mande | Independent Director | 2026 |
| Venkateswar Reddy Gogireddy | CS / Compliance Officer / Vice President - Legal | 2026 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Pharmaceuticals | ₹1,148 Cr | 99% |
| Infosystems | ₹12 Cr | 1% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| Outside India | ₹1,016 Cr | 49.1% |
| Within India | ₹1,053 Cr | 50.9% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹2 | 111 | 108 | 108 |
Corporate Actions
| Type | Date | Value | Remark |
|---|---|---|---|
| forthcoming | 2026-07-24 | Board Meetings | — |
| dividend | 2026-05-08 | ₹1.2 (60%) | Interim 2 |
| dividend | 2025-10-31 | ₹0.8 (40%) | Interim 1 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2026 | 1,449 | 16 | 49 | 123 | 33 | 1,672 |
| 2026 | 454 | 9 | 49 | 0 | 0 | 512 |
| 2026 | 894 | 7 | 0 | 123 | 30 | 1,056 |
Insider / Designated-Person Trades
20 recent disclosure(s)
PRATHIMA CHAVAPledge · 2,00,000
Mrs. G. SreelakshmiDisposal · 10,000
Venkata Jayasree Kumari TadikondaAcquisition · 788
Venkata Jayasree Kumari TadikondaAcquisition · 3,992
Venkata Jayasree Kumari TadikondaAcquisition · 2,906
MADHURI MEDASANIAcquisition · 10,000
Substantial Acquisitions (SAST)
2 disclosure(s)
Market18/02/2026 · 1,11,064
Market29/07/2025 · 8,58,801
Company Information
Incorporated2005
ChairmanRavindranath Kancherla
AuditorDeloitte Haskins & Sells LLP
Investor Email[email protected]; [email protected]
📍 Plot No 21 Jawaharlal Nehru, Pharma City Parawada, Visakhapatnam, Andhra Pradesh, 531021
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search